You are here
Symposium at ECTRIMS 2015 – Welcome
The satellite symposium was sponsored by Merck KGaA, Darmstadt, Germany
Mark S. Freedman10/28/2015 - 15:40According to Professor Freedman, treatment of multiple sclerosis should delay or prevent the accumulation of permanent disability and should be evaluated over a prolonged time frame, with an absolute minimum of 2 years of therapy.
Alexandre Prat10/28/2015 - 16:48Dr. Prat discussed the selection of drugs for the treatment of multiple sclerosis.Therapy choices must be based on adequate disease control, safety, tolerability, adherence, safety monitoring and concomitant medication.